RNA-seq profiling of plasma EVs isolated from metastatic melanoma patients showed a decrease in several transcripts and pathways related to CD28 costimulatory, T-cell receptor, and CTLA4 signaling during treatment with ICIs in non-responders. The gene discussed is CTLA4; the disease is metastatic melanoma.